Bahrain vs Cape Verde: HIV-positive TB patients on ART (antiretroviral therapy)
Bahrain
100.0%
in 2023
Cape Verde
100.0%
in 2024
Bahrain rank
1st
Cape Verde rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Bahrain
- Cape Verde
How they compare
Bahrain currently reports 100.0% against 100.0% in Cape Verde, a difference of 0.0%.
The two have swapped places 4 times across 9 shared years of data; in 2012 it was Cape Verde ahead.
Bahrain ranks 1st and Cape Verde ranks 1st of 144 countries.
Cape Verde has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahrain | Cape Verde | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 70.8% | 95.8% | 25.0% | Cape Verde |
| 2020s | 57.5% | 88.0% | 30.5% | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Bahrain or Cape Verde?
- Bahrain, at 100.0% against 100.0% in Cape Verde as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Bahrain and Cape Verde?
- 0.0%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Cape Verde?
- 9 years are reported by both, from 2012 to 2023.
- How do Bahrain and Cape Verde rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Bahrain ranks 1st and Cape Verde ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.